Yunbo Zhao

The protective role of selenium on the toxicity of cisplatin-contained chemotherapy regimen in cancer patients

Jun Hu, Yan Chen, Yongqiang Zhang et al. · Biological Trace Element Research · 1997 · 121 citations

Medicine, Oncology, Pharmacology +15

Real-world outcomes of regorafenib combined with immune checkpoint inhibitors in patients with advanced or metastatic microsatellite stable colorectal cancer: A multicenter study

Kaili Yang, Lu Han, Shikai Wu et al. · Cancer Immunology Immunotherapy · 2021 · 29 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Phase I safety and pharmacokinetic study of bevacizumab in Chinese patients with advanced cancer.

Jianyu Wu, Xiaonan Wu, Li Ding et al. · PubMed · 2010 · 26 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

Successful treatment with pazopanib plus PD-1 inhibitor and RAK cells for advanced primary hepatic angiosarcoma: a case report

Yu Qiao, Jihong Yang, Lili Liu et al. · BMC Cancer · 2018 · 24 citations · Full text

Medicine, Oncology, Pharmacology +17

S-1 plus oxaliplatin versus S-1 plus cisplatin as first-line treatment for advanced diffuse-type or mixed-type gastric/gastroesophageal junction adenocarcinoma: A randomized, phase 3 trial.

Rui‐Hua Xu, Zhi‐Qiang Wang, Lin Shen et al. · Journal of Clinical Oncology · 2019 · 24 citations

Medicine, Oncology, Pharmacology +14